Funds · CNCR

Who owns CNCR?

No institutional manager reported a Loncar Cancer Immunotherapy ETF position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

CNCR news and filings · Top funds